Market Cap : 491.16 M | Enterprise Value : 974.51 M | PE Ratio : At Loss | PB Ratio : 0.64 |
---|
NAS:ZIMV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:ZIMV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. ZimVie's cash to debt ratio for the quarter that ended in Jun. 2022 was 0.22.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, ZimVie couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2022.
The historical rank and industry rank for ZimVie's Cash-to-Debt or its related term are showing as below:
During the past 4 years, ZimVie's highest Cash to Debt Ratio was 1.73. The lowest was 0.17. And the median was 0.28.
The historical data trend for ZimVie's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, ZimVie's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ZimVie's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where ZimVie's Cash-to-Debt falls into.
This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.
ZimVie's Cash to Debt Ratio for the fiscal year that ended in Dec. 2021 is calculated as:
Cash to Debt Ratio | = | Cash, Cash Equivalents, Marketable Securities | / | Total Debt | ||
= | Cash, Cash Equivalents, Marketable Securities | / | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | |
= | 100.4 | / | (12.6 | + | 45.3) | |
= | 1.73 |
ZimVie's Cash to Debt Ratio for the quarter that ended in Jun. 2022 is calculated as:
Cash to Debt Ratio | = | Cash, Cash Equivalents, Marketable Securities | / | Total Debt | ||
= | Cash, Cash Equivalents, Marketable Securities | / | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | |
= | 130.052 | / | (26.602 | + | 577.67) | |
= | 0.22 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Thank you for viewing the detailed overview of ZimVie's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.
Crawford Sally | director | C/O HOLOGIC, INC. BEDFORD MA 01730 |
Kuntz Richard | director | MEDTRONIC, INC. 710 MEDTRONIC PWKY MS LC 310 MINNEAPOLIS MN 55432 |
Asar Vinit K | director | 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 |
Matusinec Karen | director | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
King David P | director | PRIVIA HEALTH GROUP, INC. 950 N. GLEBE RD., SUITE 700 ARLINGTON VA 22203 |
Zimmer Biomet Holdings, Inc. | 10 percent owner | 345 EAST MAIN STREET WARSAW IN 46580 |
Whitney Rebecca Ann | officer: See Remarks | 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Harmon David John | officer: See Remarks | 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Jamali Vafa | director, officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Kanaglekar Indraneel | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Kidwell Heather | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Schneider Sandra | officer: Chief Accounting Officer | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Heppenstall Richard | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
From GuruFocus
Other Sources